These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 575123)

  • 41. Concepts for controlling drug-resistant tumor cells.
    Schabel FM; Skipper HE; Trader MW; Laster WR; Corbett TH; Griswold DP
    Eur J Cancer (1965); 1980; Suppl 1():199-211. PubMed ID: 6947891
    [No Abstract]   [Full Text] [Related]  

  • 42. Effect of radiation-sensitizing agents in radiation therapy of mouse mammary carcinoma.
    Suit HD; Hewitt R; Urano M
    Radiology; 1970 Jan; 94(1):189-95. PubMed ID: 5410341
    [No Abstract]   [Full Text] [Related]  

  • 43. In vivo resistance towards anthracyclines, etoposide, and cis-diamminedichloroplatinum(II).
    Seeber S; Osieka R; Schmidt CG; Achterrath W; Crooke ST
    Cancer Res; 1982 Nov; 42(11):4719-25. PubMed ID: 6889912
    [TBL] [Abstract][Full Text] [Related]  

  • 44. An adduct of cis-diamminedichloroplatinum(II) and poly(ethylene glycol)poly(L-lysine)-succinate: synthesis and cytotoxic properties.
    Bogdanov AA; Martin C; Bogdanova AV; Brady TJ; Weissleder R
    Bioconjug Chem; 1996; 7(1):144-9. PubMed ID: 8742003
    [TBL] [Abstract][Full Text] [Related]  

  • 45. cis-Diamminedichloroplatinum(II): a metal complex with significant anticancer activity.
    Von Hoff DD; Rozencweig M
    Adv Pharmacol Chemother; 1979; 16():273-98. PubMed ID: 382800
    [No Abstract]   [Full Text] [Related]  

  • 46. Studies on the resistance of a murine leukemia L1210 cell line cis-diamminedichloroplatinum (II).
    Eastman A; Bresnick E
    Biochem Pharmacol; 1981 Oct; 30(19):2721-3. PubMed ID: 7197523
    [No Abstract]   [Full Text] [Related]  

  • 47. DNA damage induced in T50/80 tumour cells following exposure to the bioreductive drug Tirapazamine in combination with a single dose of radiation (12Gy).
    Friery OP; Hejmadi MV; McKeown SR
    Biochem Soc Trans; 1997 Feb; 25(1):135S. PubMed ID: 9057033
    [No Abstract]   [Full Text] [Related]  

  • 48. Radiosensitization of murine tumors by Fluosol-DA 20%.
    Lee I; Levitt SH; Song CW
    Radiat Res; 1990 Jun; 122(3):275-9. PubMed ID: 2113298
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Selective reduction of cis-diamminedichloroplatinum(II) nephrotoxicity by ebselen.
    Baldew GS; McVie JG; van der Valk MA; Los G; de Goeij JJ; Vermeulen NP
    Cancer Res; 1990 Nov; 50(21):7031-6. PubMed ID: 2208170
    [TBL] [Abstract][Full Text] [Related]  

  • 50. RSR13, a synthetic allosteric modifier of hemoglobin, as an adjunct to radiotherapy: preliminary studies with EMT6 cells and tumors and normal tissues in mice.
    Rockwell S; Kelley M
    Radiat Oncol Investig; 1998; 6(5):199-208. PubMed ID: 9822166
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A more general role for WR-2721 in cancer therapy.
    Yuhas JM
    Br J Cancer; 1980 May; 41(5):832-4. PubMed ID: 6252918
    [No Abstract]   [Full Text] [Related]  

  • 52. Experimental studies on the radiation-modifying effect of bleomycin in malignant and normal mouse tissue in vivo.
    Molin J; Søgaard PE; Overgaard J
    Cancer Treat Rep; 1981; 65(7-8):583-9. PubMed ID: 6166372
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Anti-tumor effects of tumor necrosis factor alone or combined with radiotherapy.
    Sersa G; Willingham V; Milas L
    Int J Cancer; 1988 Jul; 42(1):129-34. PubMed ID: 3391701
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Improving the radiation response in a C3H mouse mammary carcinoma by normobaric oxygen or carbogen breathing.
    Grau C; Horsman MR; Overgaard J
    Int J Radiat Oncol Biol Phys; 1992; 22(3):415-9. PubMed ID: 1735671
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Human central nervous system distribution of cis-diamminedichloroplatinum and use as a radiosensitizer in malignant brain tumors.
    Stewart DJ; Leavens M; Maor M; Feun L; Luna M; Bonura J; Caprioli R; Loo TL; Benjamin RS
    Cancer Res; 1982 Jun; 42(6):2474-9. PubMed ID: 6280860
    [No Abstract]   [Full Text] [Related]  

  • 56. Anginex synergizes with radiation therapy to inhibit tumor growth by radiosensitizing endothelial cells.
    Dings RP; Williams BW; Song CW; Griffioen AW; Mayo KH; Griffin RJ
    Int J Cancer; 2005 Jun; 115(2):312-9. PubMed ID: 15688384
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Influence of chk1 and plk1 silencing on radiation- or cisplatin-induced cytotoxicity in human malignant cells.
    Gao Q; Huang X; Tang D; Cao Y; Chen G; Lu Y; Zhuang L; Wang S; Xu G; Zhou J; Ma D
    Apoptosis; 2006 Oct; 11(10):1789-800. PubMed ID: 16927022
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Modulation of alkylating agents by etanidazole and Fluosol-DA/carbogen in the FSaIIC fibrosarcoma and EMT6 mammary carcinoma.
    Teicher BA; Herman TS; Tanaka J; Eder JP; Holden SA; Bubley G; Coleman CN; Frei E
    Cancer Res; 1991 Feb; 51(4):1086-91. PubMed ID: 1825474
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Combined modality treatment with ternary Cu(II) complexes and X rays.
    O'Hara JA; Douple EB; Abrams MJ; Giandomenico CM; Bradley FC; McElligott MA; Caruso FS
    Int J Radiat Oncol Biol Phys; 1992; 22(3):607-12. PubMed ID: 1735700
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Combination of cisplatin and radiation in cell culture: effect of duration of exposure to drug and timing of irradiation.
    Gorodetsky R; Levy-Agababa F; Mou X; Vexler AM
    Int J Cancer; 1998 Feb; 75(4):635-42. PubMed ID: 9466668
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.